StockTipsArenaBeta

BUY Marksans Pharma Limited — Siddharth Rai Mangala

BUYMarksans Pharma Limited
Marksans Pharma share price target & all analyst calls

bySiddharth Rai MangalaHorizon: NA (inferred 1–3 months)11 Jun 2026via Zee Business (Live)

Entry₹255.03Stated
Target₹350
Total upside +37.24% (call closed)
Stop loss₹190-25.50% risk
At expiry₹330.411 Sept 2026, 3:30 pm
Expired+29.55%
Follow Siddharth Rai Mangala for new calls(38% target hit, 16 closed calls)Get alertsWatch MARKSANS for new buy/sell callsGet alertsSee 1 active Short-term call on MARKSANSSee 32 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Sept 2026
11 supporting3 neutral0 opposing
Supports the BUY call (11)

1 advisor has an active long-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·31 Aug · 2w ago

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·18 Aug · 3w ago

Neutral / worth noting (3)

Mazagon Dock, Marksans Pharma, NIIT Learning Systems, Natco Pharma Dividends: Last Day To Buy Shares To Qualify

NewsNdtv-Profit·19 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Marksans Pharma

All analyst calls on Marksans Pharma

More from Siddharth Rai Mangala

Every call and its outcome